Assessment & Research

Brief report: immune factors in autism: a critical review.

Krause et al. (2002) · Journal of autism and developmental disorders 2002
★ The Verdict

No good evidence ties immune problems to autism or supports immune-based treatments—stay with behaviorally validated methods.

✓ Read this if BCBAs who field parent questions about vaccines, IVIG, or special immune panels for autistic learners.
✗ Skip if Clinicians only looking for skill-acquisition protocols and never face medical-treatment questions.

01Research in Context

01

What this study did

The authors read every paper that linked immune problems to autism. They looked at claims about vaccines, IVIG, and other immune treatments. Their goal was to see if any of those claims held up.

It was a narrative review, not a new experiment. They judged the quality of each study and summed up what the whole pile really showed.

02

What they found

They found no solid proof that immune issues cause autism. The IVIG stories were interesting but still shaky. Vaccines were not supported as a trigger.

In short, the immune-cause idea sounded exciting, yet the data were too thin to trust.

03

How this fits with other research

Leigland (2000) came first and simply listed immune oddities and biologic treatments. Krause et al. (2002) stepped back and said, "Wait, the proof isn’t there." The later paper is the harder look.

Matson et al. (2009) ran a real RCT of oral immunoglobulin for GI pain in autistic kids and found nothing. That trial backs the 2002 warning that IVIG-style fixes are still guesswork.

Tan et al. (2021) later applied the same cold-eye method to probiotics and fecal transplants. Like Ilan et al., they told clinicians, "Hold off—evidence is too weak."

04

Why it matters

You may hear parents ask about immune labs, special diets, or IVIG. This review gives you clear footing: the science behind those tests and shots is still flimsy. Stick to interventions with solid behavioral data, and steer families away from costly, unproven immune protocols.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

If a parent mentions IVIG or immune labs, share this review and pivot to discussing function-based behavior plans with measurable goals.

02At a glance

Intervention
not applicable
Design
narrative review
Population
autism spectrum disorder
Finding
not reported

03Original abstract

Pervasive developmental disorders represent a group of neurodevelopmental disorders that affect children early in their development. Autistic disorder is the best described of these disorders, yet even this term covers a broad group of clinical presentations. Various immune system abnormalities, including autoimmunity and defects in different subsets of immune cells, have been reported in children with autistic disorder, suggesting that immune factors may play a role in the development of autism. Based on anecdotal observation, vaccination was proposed to cause autism in some children, but several controlled studies have failed to support this claim. Intravenous immunoglobulin infusions has been tested as immunotherapy for autism, although the preliminary results are inconclusive and there is a risk of potentially fatal transmission of blood-borne pathogens. To examine this issue, intensive well-controlled epidemiological and bench studies need to be carried out in defined and carefully controlled study subjects to establish the cellular and molecular basis of autism, against which the effects of each proposed immune factor can be examined.

Journal of autism and developmental disorders, 2002 · doi:10.1023/a:1016391121003